Preliminary results from FLAGSHP-1: A Phase I dose escalation study of ERAS-601, a potent SHP2 inhibitor, in patients with previously treated advanced or metastatic solid tumors

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2022-10, Vol.174, p.S34-S34
Main Authors: McKean, M., Barve, M., Hong, D., Parikh, A., Rosen, E., Yang, J., Picard, R., Yi, J., Brail, L., Vecchio, D., Meniawy, T., John, T., Wang, J.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(22)00890-5